Shiri "Rinzai" (Allunan)

A medicament "Rinzai Lorsept" User Aikace-aikacen classifies a asibiti-pharmacological kungiyar magunguna iri iri amfani da topically a Dentistry da ENT yi.

Shiri samar a cikin nau'i na alluna ga tsotsa zagaye biconvex siffar.

Za ka iya sayan magani a tambaya da orange dandano. Yana yana da wadannan abun da ke ciki: 1.2 milligram 2.4-dichlorobenzyl barasa da amylmetacresol ɗari shida micrograms (aiki halin yanzu bangaren). Bugu da kari, akwai karin gyara (citric acid monohydrate, ruwa dextrose, sucrose, anisi mai, yellow fenti da kuma orange man) dauke a cikin samfurin "Rinzai".

Allunan da lemun tsami dandano da wannan ingantaccen da kuma gwada yawa abun da ke ciki na asali abubuwa, amma ya bambanta daga sama-aka bayyana ƙarin aka gyara. A karshen suna wakilta a rawaya colorant, a daɗin ci Mint mai, lemun tsami da man fetur, ruwa dextrose, anisi mai, sucrose.

Drug "Rinzai" (Allunan) kuma za a iya saya tare da dandano na blackcurrant da zuma.

Ya ce medicament da ciwon antimycotic sakamako. Shi ne aiki da gram-tabbatacce kuma gram-korau pathogens.

Wannan medicament aka nuna domin lura da cututtuka da kuma kumburi cututtuka na pharynx da na baka cututtuka - pharyngitises, stomatitis, glossitis, gingivitis da canker miyakunsa. Da miyagun ƙwayoyi ne contraindicated idan haƙuri da shekaru - a kalla shekaru shida, da kuma masu hypersensitive to da aka gyara.

Pharmaceutical halitta "Rinzai Lorsept". Shawarar sashi da kuma Hanyar gwamnati

Yara suka yi ta kai shekara shida, kazalika da adult marasa lafiya sanya daya kwamfutar hannu kowane biyu zuwa uku ba. Matsakaicin warkewa sakamako aka samu tare da cikakken resorption na medicament. A dare za ka iya amfani da a kalla takwas Allunan. Amfani ce medicament kamata faruwa a farko alamun kumburi daga cikin makogwaro, ko buccal kogo. Musamman ya furta cewa, idan bayan kwanaki uku daga farkon na liyafar da miyagun ƙwayoyi cututtuka nace, ya kamata ka nemi m likita shawara. Kara shawarar sashi ba haifar da kayan haɓɓaka aiki na warkewa sakamako samar medicament.

Facts yawan abin sama da miyagun ƙwayoyi ba a saita (idan aka yi amfani da a da shawarar sashi). Kuma saukar da wani lokuta na wašanda ba'aso miyagun ƙwayoyi interactions "Rinzai" (Allunan) tare da sauran magunguna. Lokacin wucewa mafi kyau duka adadin kullum magani iya samun rashin jin daɗi a cikin ciki yankin. A wannan yanayin, a symptomatic far.

Mutane da tarihi na ciwon sukari, ya kamata ya yi la'akari da cewa a cikin rãyuwar pharmaceutical sugar dauke da makaman.

A saduwa da wakili don mata suke ciki da kuma lactating mata ne da za'ayi na musamman da halartar likita.

Amfani da wani Pharmaceutical shiri "Rinzai" (Allunan) zai iya haifar da ci gaban rashin lafiyan halayen. A cikin ikon fitar da motocin da kuma aiki tare da shi ba zai tasiri a sunadaran.

An sano medicament ya kamata a adana a bushe wuri a zazzabi ba wucewa talatin digiri Celsius. Saya shi a Pharmacy ba tare da takardar sayen magani iya zama.

Shiryayye rayuwar arba'in da takwas watanni daga ranar fitowa daga cikin miyagun ƙwayoyi (an nuna a kan kunshin). A bayan yin amfani da miyagun ƙwayoyi iya zama haɗari ga lafiyarka.